A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury
Research payments
$2,623,502
Through program year 2024, $2,623,502 in research payments was reported against A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury, across 221 payments.
- Paid by (largest first)
- Mitsubishi Tanabe Pharma America, Inc.; Mitsubishi Tanabe Pharma Development America, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $998,476 | 121 |
| 2023 | Research | $649,362 | 51 |
| 2022 | Research | $749,761 | 36 |
| 2021 | Research | $225,903 | 13 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Michael McGinity San Antonio, TX Named on 10 payments
- Saman Shabani Milwaukee, WI Named on 9 payments
- Matthew Karek Grand Rapids, MI Named on 8 payments
- Puya Alikhani Tampa, FL Named on 8 payments
- Julie Rizzo Fort Sam Houston, TX Named on 7 payments
- Michael Charles Tulsa, OK Named on 7 payments
- Zubair Ahammad Toledo, OH Named on 6 payments
- Wilson Ray Saint Louis, MO Named on 5 payments
- Josiah Orina Portland, OR Named on 5 payments
- Narlin Beaty Tallahassee, FL Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.